Literature DB >> 16757688

Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures.

Maxim A Vodyanik1, James A Thomson, Igor I Slukvin.   

Abstract

During hematopoietic differentiation of human embryonic stem cells (hESCs), early hematopoietic progenitors arise along with endothelial cells within the CD34(+) population. Although hESC-derived hematopoietic progenitors have been previously identified by functional assays, their phenotype has not been defined. Here, using hESC differentiation in coculture with OP9 stromal cells, we demonstrate that early progenitors committed to hematopoietic development could be identified by surface expression of leukosialin (CD43). CD43 was detected on all types of emerging clonogenic progenitors before expression of CD45, persisted on differentiating hematopoietic cells, and reliably separated the hematopoietic CD34(+) population from CD34(+)CD43(-)CD31(+)KDR(+) endothelial and CD34(+)CD43(-)CD31(-)KDR(-) mesenchymal cells. Furthermore, we demonstrated that the first-appearing CD34(+)CD43(+)CD235a(+)CD41a(+/-)CD45(-) cells represent precommitted erythro-megakaryocytic progenitors. Multipotent lymphohematopoietic progenitors were generated later as CD34(+)CD43(+)CD41a(-)CD235a(-)CD45(-) cells. These cells were negative for lineage-specific markers (Lin(-)), expressed KDR, VE-cadherin, and CD105 endothelial proteins, and expressed GATA-2, GATA-3, RUNX1, C-MYB transcription factors that typify initial stages of definitive hematopoiesis originating from endothelial-like precursors. Acquisition of CD45 expression by CD34(+)CD43(+)CD45(-)Lin(-) cells was associated with progressive myeloid commitment and a decrease of B-lymphoid potential. CD34(+)CD43(+)CD45(+)Lin(-) cells were largely devoid of VE-cadherin and KDR expression and had a distinct FLT3(high)GATA3(low)RUNX1(low)PU1(high)MPO(high)IL7RA(high) gene expression profile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757688      PMCID: PMC1895535          DOI: 10.1182/blood-2006-02-003327

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

1.  CD43 interferes with T-lymphocyte adhesion.

Authors:  B Ardman; M A Sikorski; D E Staunton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis.

Authors:  M R Loken; C I Civin; W L Bigbee; R G Langlois; R H Jensen
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

3.  Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage.

Authors:  C Peschle; F Mavilio; A Carè; G Migliaccio; A R Migliaccio; G Salvo; P Samoggia; S Petti; R Guerriero; M Marinucci
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

4.  Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.

Authors:  C S Shelley; E Remold-O'Donnell; A E Davis; G A Bruns; F S Rosen; M C Carroll; A S Whitehead
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Induction of CD43 expression during activation and terminal differentiation of human B cells.

Authors:  M Wikén; P Björck; B Axelsson; P Perlmann
Journal:  Scand J Immunol       Date:  1988-10       Impact factor: 3.487

Review 6.  The platelet membrane glycoprotein IIb-IIIa complex.

Authors:  D R Phillips; I F Charo; L V Parise; L A Fitzgerald
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

7.  CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.

Authors:  Y Rosenstein; J K Park; W C Hahn; F S Rosen; B E Bierer; S J Burakoff
Journal:  Nature       Date:  1991-11-21       Impact factor: 49.962

8.  Cross-linking of sialophorin (CD43) induces neutrophil aggregation in a CD18-dependent and a CD18-independent way.

Authors:  T W Kuijpers; M Hoogerwerf; K C Kuijpers; B R Schwartz; J M Harlan
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

9.  The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis.

Authors:  Nikla R Emambokus; Jonathan Frampton
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

10.  Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome.

Authors:  E Remold-O'Donnell; C Zimmerman; D Kenney; F S Rosen
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

View more
  164 in total

1.  Characterization of human embryonic stem cell-derived hematopoietic progenitor phenotype.

Authors:  Hai-Yang Zhou; Xiao-Yi Yang; Li-Jian Tao; Yue-Tian Chang; Ru-Ping Dai
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-07-10       Impact factor: 2.416

Review 2.  Generation of mature hematopoietic cells from human pluripotent stem cells.

Authors:  Padma Priya Togarrati; Kran Suknuntha
Journal:  Int J Hematol       Date:  2012-05-31       Impact factor: 2.490

Review 3.  Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.

Authors:  Igor I Slukvin
Journal:  FEBS Lett       Date:  2016-07-22       Impact factor: 4.124

4.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Authors:  Zhihong Wan; Ning Zhi; Susan Wong; Keyvan Keyvanfar; Delong Liu; Nalini Raghavachari; Peter J Munson; Su Su; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

5.  Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4.

Authors:  J Philip Creamer; Carissa Dege; Qihao Ren; Jolie T K Ho; Mark C Valentine; Todd E Druley; Christopher M Sturgeon
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

6.  In vitro clonal analysis of murine pluripotent stem cells isolated from skeletal muscle and adipose stromal cells.

Authors:  Jamie Case; Tamara L Horvath; Christopher B Ballas; Keith L March; Edward F Srour
Journal:  Exp Hematol       Date:  2007-11-26       Impact factor: 3.084

7.  Concurrent generation of functional smooth muscle and endothelial cells via a vascular progenitor.

Authors:  Melanie Marchand; Erica K Anderson; Smruti M Phadnis; Michael T Longaker; John P Cooke; Bertha Chen; Renee A Reijo Pera
Journal:  Stem Cells Transl Med       Date:  2013-12-05       Impact factor: 6.940

8.  Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.

Authors:  Iléana Antony-Debré; Vladimir T Manchev; Nathalie Balayn; Dominique Bluteau; Cécile Tomowiak; Céline Legrand; Thierry Langlois; Olivia Bawa; Lucie Tosca; Gérard Tachdjian; Bruno Leheup; Najet Debili; Isabelle Plo; Jason A Mills; Deborah L French; Mitchell J Weiss; Eric Solary; Remi Favier; William Vainchenker; Hana Raslova
Journal:  Blood       Date:  2014-12-09       Impact factor: 22.113

9.  EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.

Authors:  Enrique C Torchia; Kelli Boyd; Jerold E Rehg; Chunxu Qu; Suzanne J Baker
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

10.  Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells.

Authors:  Petter S Woll; Julie K Morris; Matt S Painschab; Rebecca K Marcus; Aimee D Kohn; Travis L Biechele; Randall T Moon; Dan S Kaufman
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.